Anthem Biosciences vs Aarti Pharmalabs vs Chemplast Sanmar: Which Stock Should You Track

Anthem Biosciences vs Aarti Pharmalabs vs Chemplast Sanmar starts with the core numbers most investors compare within the Pharma and Biosciences segment: market capitalisation, valuation multiples, profitability and dividend yield. Figures below are sourced as of September 2026 and will shift with daily price moves.

All three names sit in the Pharma and Biosciences bucket, which makes them a natural set to place side by side rather than a random trio of unrelated businesses.

Click Here – Get Free Investment Predictions

Anthem Biosciences, Aarti Pharmalabs and Chemplast Sanmar: Company Overview

Anthem Biosciences is a listed Indian company in the Pharma and Biosciences space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.

Aarti Pharmalabs is a listed Indian company in the Pharma and Biosciences space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.

Chemplast Sanmar is a listed Indian company in the Pharma and Biosciences space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.

Anthem Biosciences vs Aarti Pharmalabs vs Chemplast Sanmar: Valuation and Profitability Snapshot

Metric	Anthem Biosciences	Aarti Pharmalabs	Chemplast Sanmar
Market Cap (approx.)	Rs 49,255 crore	Rs 8,288 crore	Rs 3,134 crore
PE Ratio (TTM)	85.55	38.88	NA
PB Ratio	16.19	3.90	0.00
Return on Equity (ROE)	19.45%	8.22%	-7.41%
EPS (TTM, Rs)	10.22	23.51	-24.74
Dividend Yield	0.23%	0.38%	0.00%
Debt to Equity	0.02	0.36	1.11
Book Value per Share (Rs)	54.01	234.30	-6.33

Check the Univest Screener for Live Data

On valuation, Anthem Biosciences trades at a PE of 85.55 and a PB of 16.19, Aarti Pharmalabs at a PE of 38.88 and a PB of 3.90, while Chemplast Sanmar trades at a PE of NA and a PB of 0.00. On return on equity, the three post 19.45%, 8.22% and -7.41% respectively, and on dividend yield they stand at 0.23%, 0.38% and 0.00%.

Anthem Biosciences vs Aarti Pharmalabs vs Chemplast Sanmar: Latest Quarterly Results

Company	Latest Quarter Revenue	Latest Quarter Net Profit	YoY Change (Revenue)	QoQ Change (Revenue)
Anthem Biosciences	Rs 443.11 crore	Rs 119.94 crore	-21.3%	-33.1%
Aarti Pharmalabs	Rs 536.25 crore	Rs 76.14 crore	+38.3%	-9.2%
Chemplast Sanmar	Rs 1,127.19 crore	-Rs 175.58 crore	+1.6%	-10.7%

Quarterly figures above are the most recent reported quarter for each company (Q1 FY27, quarter ended June 2026), compared with the year-ago and preceding quarter.

Download the Univest iOS App or Univest Android App to track Anthem Biosciences, Aarti Pharmalabs and Chemplast Sanmar live prices.

What Should Investors Look at Beyond These Numbers?

Beyond the metrics above, investors comparing these three pharma and biosciences names should track quarter-on-quarter revenue and margin trends, management commentary on demand and cost drivers, and any sector-specific regulatory developments, since a single-quarter snapshot can shift quickly.

Conclusion

Anthem Biosciences vs Aarti Pharmalabs vs Chemplast Sanmar highlights how differently three companies in the same pharma and biosciences segment can score across valuation, profitability and dividend metrics, even when operating in a similar space. This comparison does not declare a winner; investors should weigh these figures against their own research and risk appetite. Please read the disclaimer below before making any investment decision.

FAQs on Anthem Biosciences vs Aarti Pharmalabs vs Chemplast Sanmar

What is the market cap difference between Anthem Biosciences, Aarti Pharmalabs and Chemplast Sanmar?

Ans. As of September 2026, Anthem Biosciences has a market cap of approximately Rs 49,255 crore, Aarti Pharmalabs is at approximately Rs 8,288 crore, and Chemplast Sanmar is at approximately Rs 3,134 crore.

Which of the three has the highest PE ratio?

Ans. Among Anthem Biosciences, Aarti Pharmalabs and Chemplast Sanmar, the PE ratios stand at 85.55, 38.88 and NA respectively as of September 2026.

Which of the three has the highest ROE?

Ans. Anthem Biosciences, Aarti Pharmalabs and Chemplast Sanmar post ROE of 19.45%, 8.22% and -7.41% respectively as of September 2026.

Which of these three stocks pays the highest dividend yield?

Ans. Anthem Biosciences, Aarti Pharmalabs and Chemplast Sanmar carry dividend yields of 0.23%, 0.38% and 0.00% respectively.

What is the debt to equity ratio for Anthem Biosciences, Aarti Pharmalabs and Chemplast Sanmar?

Ans. Anthem Biosciences carries a debt to equity of 0.02, Aarti Pharmalabs of 0.36, and Chemplast Sanmar of 1.11.

Which of the three trades at the highest price to book value?

Ans. Anthem Biosciences, Aarti Pharmalabs and Chemplast Sanmar trade at price to book ratios of 16.19, 3.90 and 0.00 respectively.

Is one of Anthem Biosciences, Aarti Pharmalabs or Chemplast Sanmar better than the others?

Ans. This comparison does not declare one stock better than another; each company scores differently across valuation, profitability and dividend metrics, and the right fit depends on an individual investor's own criteria and research.